[1] Chang YJ, Liu JW, Lin PC, et al. Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis. Life Sci. 2009;85(13-14):517-525.
[2] 周达,王晶,何玲楠,等.慢病毒介导的脯氨酰寡肽酶过表达对大鼠肝星状细胞功能的影响[J].胃肠病学和肝病学杂志,2018,27(4): 393-398.
[3] Chen YW, Liu BW, Zhang YJ, et al. Preservation of basal AcSDKP attenuates carbon tetrachloride-induced fibrosis in the rat liver. J Hepatol. 2010;53(3):528-536.
[4] Suzuki Y, Katagiri F, Sato F, et al. Significant decrease in plasma N-acetyl-seryl-aspartyl-lysyl-proline level in patients with end stage renal disease after kidney transplantation. Biol Pharm Bull. 2014;37(6): 1075-1079.
[5] Cho KA, Lim GW, Joo SY, et al. Transplantation of bone marrow cells reduces CCl4 -induced liver fibrosis in mice. Liver Int. 2011;31(7): 932-939.
[6] Tsuchiya A, Takeuchi S, Watanabe T, et al. Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration. Inflamm Regen. 2019;39:18.
[7] Yin F, Wang WY, Jiang WH. Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis in vitro and in vivo: From biological characteristics to therapeutic mechanisms. World J Stem Cells. 2019; 11(8):548-564.
[8] Tenorio-Laranga J, Montoliu C, Urios A, et al. The expression levels of prolyl oligopeptidase responds not only to neuroinflammation but also to systemic inflammation upon liver failure in rat models and cirrhotic patients. J Neuroinflammation. 2015;12:183.
[9] Zhou D, Wang J, He LN, et al. Prolyl oligopeptidase attenuates hepatic stellate cell activation through induction of Smad7 and PPAR-γ. Exp Ther Med. 2017;13(2):780-786.
[10] Dewidar B, Meyer C, Dooley S, et al. TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. Cells. 2019;8(11): 1419.
[11] Yang KL, Chang WT, Hong MY, et al. Prevention of TGF-β-induced early liver fibrosis by a maleic acid derivative anti-oxidant through suppression of ROS, inflammation and hepatic stellate cells activation. PLoS One. 2017;12(4):e0174008.
[12] Beljaars L, Daliri S, Dijkhuizen C, et al. WNT-5A regulates TGF-β-related activities in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2017;312(3):G219-G227.
[13] Xu F, Liu C, Zhou D, et al. TGF-beta/SMAD Pathway and Its Regulation in Hepatic Fibrosis. J Histochem Cytochem. 2016;64(3):157-167.
[14] Lin IY, Chiou YS, Wu LC, et al. CCM111 prevents hepatic fibrosis via cooperative inhibition of TGF-β, Wnt and STAT3 signaling pathways. J Food Drug Anal. 2019;27(1):184-194. |